STC-15toripalimabSTC15-24202cancermelanomaNSCLC
…ill be enrolled in the dose-escalation cohorts and administered STC-15 orally thrice weekly (TIW) at 3 escalating dose levels in combi…
1articles mentioning drugs
1drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: STC15-24202 ×
STC15-24202
This drug is selected. Its supporting articles are shown below.